Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds
Phase 2
- Conditions
- Non-healing WoundAcute Bacterial Skin and Skin Structure Infection (ABSSSI)
- Interventions
- Combination Product: Ultrasonic Drug DeliveryDrug: Standard of Care Antibiotic Treatment
- First Posted Date
- 2018-11-06
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- Sonescence, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03732365
Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
- Conditions
- Infection, Soft TissueInfection, WoundCellulitisDiabetic Foot Ulcer
- First Posted Date
- 2010-11-10
- Last Posted Date
- 2018-10-23
- Lead Sponsor
- Sonescence, Inc.
- Registration Number
- NCT01238276
- Locations
- 🇺🇸
Sonoma West Medical Center, Sebastopol, California, United States
© Copyright 2025. All Rights Reserved by MedPath